Effect of site of venous Protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstrictionCOMUNALE, Mark E; MASLOW, Andrew; ROBERTSON, Linda K et al.Journal of cardiothoracic and vascular anesthesia. 2003, Vol 17, Num 3, pp 309-313, issn 1053-0770, 5 p.Article

Enhancement of α₂-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic u46619 in the porcine isolated ear artery: role of the ERK-MAP kinase signal transduction cascadeBHATTACHARYA, B; ROBERTS, R. E.British journal of pharmacology. 2003, Vol 139, Num 1, pp 156-162, issn 0007-1188, 7 p.Article

THROMBOXANE MOLECULES DO NOT ADOPT THE PROSTAGLANDIN HAIRPIN CONFORMATIONLANGS DA; FORTIER S; ERMAN MG et al.1979; NATURE; GBR; DA. 1979; VOL. 281; NO 5728; PP. 237-238; BIBL. 19 REF.Article

Thromboxane generation after thrombin: protective effect of thromboxane synthetase inhibition on lung fluid balanceGARCIA-SZABO, R. R; PETERSON, M. B; WATKINS, W. D et al.Circulation research. 1983, Vol 53, Num 2, pp 214-222, issn 0009-7330Article

EFFECTS OF PROVOCATION ON TRANSCARDIAC THROMBOXANE IN PATIENTS WITH CORONARY ARTERY DISEASEHIRSH PD; FIRTH BG; CAMPBELL WB et al.1983; AMERICAN (THE) JOURNAL OF CARDIOLOGY; ISSN 0002-9149; USA; DA. 1983; VOL. 51; NO 5; PP. 727-733; BIBL. 39 REF.Article

Gas chromatographic-mass spectrometric determination of 11-dehydrothromboxane B₂ in human urineWEBER, C; BEETENS, J; DE CLERCK, F et al.Journal of chromatography. Biomedical applications. 1992, Vol 577, Num 1, pp 1-7, issn 0378-4347Article

A METHOD FOR MEASURING THE UNSTABLE THROMBOXANE A₂: RADIO-IMMUNOASSAY OF THE DERIVED MONO-O-METHYL-THROMBOXANE B₂.GRANSTROM E; KINDAHL H; SAMUELSSON B et al.1976; PROSTAGLANDINS; U.S.A.; DA. 1976; VOL. 12; NO 6; PP. 929-941; BIBL. 13 REF.Article

Selective thromboxane A₂ synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injuryWESTPHAL, Martin; NOSHIMA, Shinji; ISAGO, Tsukasa et al.Anesthesiology (Philadelphia). 2005, Vol 102, Num 5, pp 954-961, issn 0003-3022, 8 p.Article

Myotropic activity of leukotriene B₄ on lung parenchyma strips is not necessarily attributable to thromboxane A₂ releaseFITZPATRICK, F. A; LAWSON, C. F.The Journal of pharmacology and experimental therapeutics. 1988, Vol 245, Num 3, pp 839-844, issn 0022-3565Article

Mapping of the human thromboxane synthase gene (TBXAS1) to chromosome 7q34-q35 by two-color fluorescence in situ hybridizationCHASE, M. B; SEUNG JOON BAEK; PURTELL, D. C et al.Genomics (San Diego, Calif.). 1993, Vol 16, Num 3, pp 771-773, issn 0888-7543Article

Synthesis of dual activity molecules with thromboxane antagonist and thromboxane synthase inhibitory activityRUSSELL, K; GASKIN, H.Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 9, pp 985-986Article

Prostaglandines et thromboxanes = Prostaglandins and thromboxanesFALARDEAU, P; MARTINEAU, A; GAGNON, D et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 16, pp 1117-1136, issn 0037-1777Article

BIOSYNTHESIS AND BIOLOGICAL ACTIONS OF PROSTAGLANDINS AND THROMBOXANESHAMMARSTROEM S.1982; ARCH. BIOCHEM. BIOPHYS.; ISSN 0003-9861; USA; DA. 1982; VOL. 214; NO 2; PP. 431-445; BIBL. 46 REF.Article

Inhibition of platelet aggregation and thromboxane production by pinacidilGOODMAN, R. P; LITTLE, D. M; WRIGHT, J. T. JR et al.Prostaglandins leukotrienes and medicine. 1985, Vol 19, Num 2, pp 115-122, issn 0262-1746Article

Quantification of thromboxane and PGD₂ metabolites in biological fluidsJACKSON ROBERTS II, L; OATES, J. A.Prostaglandins. 1984, Vol 27, Num 3, pp 352-354, issn 0090-6980Article

IMIDAZOLE: A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE.MONCADA S; BUNTING S; MULLANE K et al.1977; PROSTAGLANDINS; U.S.A.; DA. 1977; VOL. 13; NO 4; PP. 611-618; BIBL. 2 P.Article

Measurement of thromboxane metabolites by gas chromatography-mass spectrometryCATELLA, F; FITZGERALD, G. A.Methods in enzymology. 1990, Vol 187, pp 42-50, issn 0076-6879, 9 p.Article

Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmoleinSANCHEZ-MUNIZ, Francisco J; OUBINA, Pilar; RODENAS, Sofia et al.European journal of nutrition (Print). 2003, Vol 42, Num 6, pp 299-306, issn 1436-6207, 8 p.Article

Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitorGHUYSEN, Alexandre; DOGNE, Jean-Michel; CHIAP, Patrice et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 1, pp 1-14, issn 0897-5957, 14 p.Article

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthaseREILLY, I. A. G; DORAN, J. B; SMITH, B et al.Circulation (New York, N.Y.). 1986, Vol 73, Num 6, pp 1300-1309, issn 0009-7322Article

Selective thromboxane inhibition: a new approach to antiplatelet therapyFISHER, M; WEINER, B; OCKENE, I. S et al.Stroke (1970). 1984, Vol 15, Num 5, pp 813-816, issn 0039-2499Article

STRONTIUM IONS INDUCE PRODUCTION OF THROMBOXANE B₂ AND SECRETION OF 5-HYDROXYTRYPTAMINE IN WASHED HUMAN PLATELETSBEST LC; BONE EA; RUSSELL RGG et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 6; PP. 635-637; BIBL. 17 REF.Article

ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASETYLER HM; SAXTON CAPD; PARRY MJ et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8221; PP. 629-632; BIBL. 6 REF.Article

A OTRUCTURAL REQUIREMENT FOR THE CONVERSION OF THE PROSTAGLANDIN ENDOPEROXIDES TO THROMBOXANESDICZFALUSY U; HAMMARSTROM S.1979; F.E.B.S. LETTERS; NLD; DA. 1979; VOL. 105; NO 2; PP. 291-295; BIBL. 8 REF.Article

THROMBOXANE B₂ TRANSFORMED FROM ARACHIDONIC ACID IN CARRAGEENIN-INDUCED GRANULOMA.WEN CHANG CHANG; SEI ITSU MUROTA; TSURUFUJI S et al.1977; PROSTAGLANDINS; U.S.A.; DA. 1977; VOL. 13; NO 1; PP. 17-24; BIBL. 16 REF.Article